Bickling Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$254K Buy
1,571
+5
+0.3% +$767 0.16% 100
2022
Q3
$211K Sell
1,566
-351
-18% -$50.4K 0.14% 109
2022
Q2
$294K Buy
1,917
+12
+0.6% +$1.83K 0.19% 90
2022
Q1
$309K Buy
1,905
+12
+0.6% +$1.74K 0.16% 98
2021
Q4
$256K Buy
+1,893
New +$224K 0.12% 113
2021
Q3
Sell
-2,821
Closed -$318K 124
2021
Q2
$318K Buy
2,821
+751
+36% +$84.6K 0.14% 91
2021
Q1
$224K Buy
+2,070
New +$221K 0.11% 104

Other funds holding ABBV

Bickling Financial Services's ABBV Position: Q4 2022 in Review

Bickling Financial Services increased its AbbVie (ABBV) stake by 0.32% in Q4 2022, buying an estimated $767 and bringing the position to 1,571 shares worth $254K. The position accounts for 0.16% of the portfolio, ranked #100.

Bickling Financial Services first reported a position in ABBV in Q1 2021 and has held it in 7 quarters since. The position peaked at $318K in Q2 2021. 3,168 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Bickling Financial Services held 1,571 shares of AbbVie worth $254K as of Q4 2022.
  • Bickling Financial Services bought 5 AbbVie shares in Q4 2022, an estimated $767.
  • AbbVie made up 0.16% of Bickling Financial Services's portfolio in Q4 2022, its #100 holding.
  • Bickling Financial Services first reported a position in AbbVie in Q1 2021 and has held it in 7 quarters since.
  • Bickling Financial Services's AbbVie position peaked at $318K in Q2 2021.
  • 3,168 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Bickling Financial Services's 13F filing for Q4 2022, filed 31 Jan 2023.